Medplus Health Services · NSE: MEDPLUS · BSE: 543427

Q3 FY23 results · Oct–Dec 2022

Medplus Health Services reported revenue from operations of ₹1,190.31 crore (up 27.5% from Q3 FY22) and net profit of ₹13.38 crore (down 20.9% from Q3 FY22) for Q3 FY23 (Oct–Dec 2022), on a consolidated basis.

Consolidated · ₹ crore
ItemQ3 FY23Q3 FY22YoYQ2 FY23QoQ
Revenue from operations1,190.31933.45+27.5%1,120.62+6.2%
Other income11.367.33+54.9%10.89+4.3%
Total income1,201.67940.79+27.7%1,131.52+6.2%
Profit before tax16.2121.75−25.5%8.82+83.8%
Net profit for the period13.3816.92−20.9%6.48+106.6%
Attributable to shareholders of the company13.4117.17−21.9%6.57+104.2%
EPS, basic (₹)1.121.53−26.8%0.55+103.6%
Net margin (%)1.11.80.6
Standalone · ₹ crore
ItemQ3 FY23Q3 FY22YoYQ2 FY23QoQ
Revenue from operations57.2424.71+131.6%42.45+34.8%
Other income4.071.12+262.4%4.26−4.7%
Total income61.3125.83+137.3%46.72+31.2%
Profit before tax1.78(1.21)Turned profit(0.82)Turned profit
Net profit for the period0.62(1.21)Turned profit(0.82)Turned profit
EPS, basic (₹)0.15(0.11)Turned profit(0.07)Turned profit
Net margin (%)1.1-4.9-1.9
Consolidated
Filed with BSE
06 Feb 2023, 14:44 IST
Board meeting
03 Feb 2023
Period
01 Oct 2022 to 31 Dec 2022
Review status
Unaudited
Source
XBRL filing on BSE
Standalone
Filed with BSE
06 Feb 2023, 14:44 IST
Board meeting
03 Feb 2023
Period
01 Oct 2022 to 31 Dec 2022
Review status
Unaudited
Source
XBRL filing on BSE